{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T18:10:49Z","timestamp":1774635049733,"version":"3.50.1"},"reference-count":0,"publisher":"Tunisian Society of Medical Sciences","issue":"4","license":[{"start":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T00:00:00Z","timestamp":1712361600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tunis Med"],"abstract":"<jats:p>Introduction\u00a0: Le traitement des fistules p\u00e9rianales complexes au cours de la maladie de Crohn (MC) reste un d\u00e9fi notamment apr\u00e8s \u00e9chec de l\u2019Infliximab.\nObjectif\u00a0: Mise au point sur les diff\u00e9rentes alternatives th\u00e9rapeutiques de la fistule anale au cours de la MC r\u00e9fractaires \u00e0 l\u2019Infliximab.\nM\u00e9thodes : Recherche a \u00e9t\u00e9 effectu\u00e9e sur PubMed et Google Scholar. Les \u00e9tudes de s\u00e9ries de malades, les essais th\u00e9rapeutiques randomis\u00e9s en double aveugle et les revues de la litt\u00e9rature ont \u00e9t\u00e9 retenus. Les \u00e9tudes d\u2019observation isol\u00e9e ou de recherche fondamentale, n\u2019ayant pas encore d\u2019applications pratiques ont \u00e9t\u00e9 \u00e9limin\u00e9es.\nR\u00e9sultats : Les anti-TNF notamment l\u2019Infliximab restent l'option th\u00e9rapeutique de choix avec une efficacit\u00e9 estim\u00e9e \u00e0 60% et un taux de perte de r\u00e9ponse non n\u00e9gligeable. De nouvelles strat\u00e9gies th\u00e9rapeutiques permettraient d\u2019offrir de nouvelles opportunit\u00e9s : par exemple, l'Ustekinumab pourrait \u00eatre efficace apr\u00e8s l'\u00e9chec du traitement par les anti-TNF, bien que des \u00e9tudes suppl\u00e9mentaires soient n\u00e9cessaires. Les r\u00e9centes guidelines sugg\u00e8rent que l'injection de cellules souches m\u00e9senchymateuses est un traitement efficace et s\u00fbr pour les fistules complexes. D\u2019autres options chirurgicales ont \u00e9t\u00e9 propos\u00e9es comme le lambeau rectal d\u2019avancement, l\u2019obturation du trajet fistuleux par de la colle ou le plug, la ligature intersphinct\u00e9rienne du trajet fistuleux mais toutes avec une efficacit\u00e9 limit\u00e9e et discutable. Compte tenu du taux d'\u00e9chec de toutes ces options, de nouvelles strat\u00e9gies th\u00e9rapeutiques sont en cours d\u2019\u00e9valuation.\nConclusion : Les fistules anales crohniennes pr\u00e9sentent un vrai challenge th\u00e9rapeutique. De nouvelles th\u00e9rapeutiques m\u00e9dico-chirurgicales sont en cours d\u2019\u00e9valuation avec des r\u00e9sultats prometteurs.<\/jats:p>","DOI":"10.62438\/tunismed.v102i4.4699","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T07:48:47Z","timestamp":1715759327000},"source":"Crossref","is-referenced-by-count":2,"title":["Traitement des fistules anales r\u00e9fractaires \u00e0 l\u2019Infliximab au cours de la maladie de Crohn : Mise au point"],"prefix":"10.62438","volume":"102","author":[{"given":"Sarra","family":"Ben Azouz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"Elleuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafa","family":"Dahmeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eya","family":"Hammami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahlem","family":"Braham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanene","family":"Jaziri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Ben Slema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Ksiaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Jmaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"31112","published-online":{"date-parts":[[2024,4,6]]},"container-title":["La Tunisie M\u00e9dicale"],"original-title":[],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T07:48:48Z","timestamp":1715759328000},"score":1,"resource":{"primary":{"URL":"https:\/\/latunisiemedicale.com\/index.php\/tunismed\/article\/view\/4699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,6]]},"references-count":0,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,6]]}},"URL":"https:\/\/doi.org\/10.62438\/tunismed.v102i4.4699","relation":{},"ISSN":["2724-7031","0041-4131"],"issn-type":[{"value":"2724-7031","type":"electronic"},{"value":"0041-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,6]]}}}